// App-Quantinova.ai

: Genetic mapping of APP and amyloid-β biology modulation by trisomy 21

Researchers

Presenter

  • Frances K Wiseman

Principal Investigators

  • Justin Tosh

  • Silvia Anderle

  • Eleni Gkanatsiou

  • Gloria Lau

  • Sue Noy

  • Karen Cleverley

  • Takashi Saito

  • Takaomi C. Saido

  • Eugene Y. Yu

  • Gunnar Brinkmalm

  • Erik Portelius

  • Kaj Blennow

  • Henrik Zetterberg

  • Victor L Tybulewicz

  • Elizabeth Fisher

Medical Centers

  • RIKEN Center for Brain Science

  • Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Moelndal, Sweden

  • Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

  • Roswell Park Comprehensive Cancer...

  • UK Dementia Research Institute, University College London

  • University of Gothenburg,

  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London

  • Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden

  • Francis Crick Institute

  • University CollegeLondon, UK

  • RIKEN Brain Science Institute

  • Institute of Neuroscience & Physiology, Department of Psychiatry & Neurochemistry, The Sahlgrenska Academy, University of Gothenburg

  • LonDownS Consortium

  • Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg

  • Hong Kong Center for Neurodegenerative Diseases

  • UK Dementia Research Institute, University College London

  • UK Dementia Research Institute

Locations

  • United Kingdom

  • Hong Kong

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Down syndrome

Biomarkers

  • Amyloid Precursor Protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved